Business
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
PLYMOUTH MEETING, Pa., Feb. 7, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to
About this update from Inovio Pharmaceuticals, Inc.
[{"type":"text","content":"PLYMOUTH MEETING, Pa., Feb. 7, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that Dr. Jacqueline Shea, President and CEO will present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference.\n\nOppenheimer 34th Annual Healthcare Life Sciences ConferenceDate: Wednesday, February 14, 2024Time: 12:40 PM ETFormat: Fireside Chat\nDuring the conference, Dr. Shea and members of INOVIO's management team will conduct one-on-one meetings with registered investors.\nA webcast of the presentation will be available on the INOVIO Investor Relations Events page at https://ir.inovio.com/events-and-presentations/default.aspx. A replay of the webcast will be available for 90 days after the date of the presentation.\nAbout INOVIOINOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.\nContactsMedia: Jennie Willson (267) 429-8567 [email protected]: Thomas Hong (267) 440-4298 [email protected]\n\n View original content:https://www.prnewswire.com/news-releases/inovio-to-present-at-the-oppenheimer-34th-annual-healthcare-life-sciences-conference-302056373.html\nSOURCE INOVIO Pharmaceuticals, Inc.","length":3037,"tagName":"div"}]